gold has been researched along with Neuroendocrine Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Freedman, EM; Gaskins, K; Kebebew, E; Kingston, DGI; Libutti, SK; Nilubol, N; Paciotti, GF; Sanchez, C; Tamarkin, L; Yuan, Z; Zhao, J | 1 |
| Azorín-Vega, E; Ferro-Flores, G; Ocampo-García, BE; Orocio-Rodríguez, E; Ramírez, Fde M; Sánchez-García, FM; Santos-Cuevas, CL | 1 |
2 other study(ies) available for gold and Neuroendocrine Tumors
| Article | Year |
|---|---|
Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.
Topics: Animals; Capillary Permeability; Cell Line, Tumor; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Gene Expression Profiling; Gold; Humans; Mice; Mice, Knockout; Molecular Targeted Therapy; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Polyethylene Glycols; Recombinant Proteins; Theranostic Nanomedicine; Thyroid Neoplasms; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2018 |
Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging.
Topics: Animals; Cell Line, Tumor; Dendrimers; Gold; Male; Metal Nanoparticles; Mice; Mice, Nude; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Rats; Somatostatin; Technetium; Tissue Distribution | 2015 |